The Potential Drug Target ST13P5: A Potential Biomarker for Proteostasis and Aging

Target Name: ST13P5

NCBI ID: G144106

ST13P5

Other Name(s): ST13, Hsp70 interacting protein pseudogene 5 | FAM10A5 | Suppression of tumorigenicity 13 (colon carcinoma) (Hsp70 interacting protein) pseudogene 5

The Potential Drug Target ST13P5: A Potential Biomarker for Proteostasis and Aging

ST13P5 (ST13, Hsp70 interacting protein pseudogene 5) is a gene that encodes a protein known to play a critical role in the regulation of protein homeostasis and metabolism. The protein encoded by this gene, ST13P5, has been shown to interact with the heat shock protein (Hsp70) and has been implicated in a variety of cellular processes, including cell survival, metabolism, and stress resistance.

Recent studies have also suggested that ST13P5 may have potential as a drug target or biomarker. In this article, we will explore the potential implications of ST13P5 as a drug target and the potential utility of ST13P5 as a biomarker for the study of aging and age-related diseases.

Potential Drug Target

The protein encoded by ST13P5 has been shown to interact with Hsp70, a protein that plays a critical role in the regulation of protein homeostasis and metabolism. This interaction suggests that ST13P5 may be a drug target that can be targeted by small molecules or other therapeutic agents to modulate its function and potentially treat a variety of diseases.

One potential mechanism by which ST13P5 may be targeted by drugs is through its role in the regulation of cellular stress response. ST13P5 has been shown to play a critical role in the regulation of cellular stress response, and alterations in its function have been implicated in a variety of age-related diseases, including cancer, neurodegenerative diseases, and cardiovascular disease.

In addition, ST13P5 has also been shown to play a critical role in the regulation of cell metabolism and metabolism-related diseases. Its function in these processes has been implicated in the development and progression of a variety of diseases, including obesity, type 2 diabetes, and neurodegenerative diseases.

Potential Biomarker

ST13P5 has also been suggested as a potential biomarker for the study of aging and age-related diseases. Its expression has been shown to decline with age, and alterations in its expression have been implicated in a variety of age-related diseases, including Alzheimer's disease, cancer, and cardiovascular disease.

In addition, ST13P5 has also been shown to play a critical role in the regulation of cellular stress response, and alterations in its function have been implicated in a variety of stress-related diseases, including anxiety and depression.

Conclusion

In conclusion, ST13P5 is a gene that has been shown to play a critical role in the regulation of protein homeostasis and metabolism, and its function in these processes has been implicated in a variety of diseases, including cancer, neurodegenerative diseases, and cardiovascular disease. Its potential as a drug target or biomarker makes it an attractive target for further study and potential therapeutic intervention. Further research is needed to fully understand the role of ST13P5 in these processes and its potential as a drug or biomarker.

Protein Name: ST13, Hsp70 Interacting Protein Pseudogene 5

The "ST13P5 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ST13P5 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets